Our analysts explore NICE's integration of tech appraisals into treatment guidelines for to enable o...
Read moreProposed changes in Germany's pharma strategy suggest replacing publicly listed AMNOG rebates with c...
Read moreAIFA's restructuring in Italy aims to streamline drug approval, replacing committees and introducing...
Read moreSpain seeks to enhance financing for orphan drug access, signalling a push for better timelines and ...
Read moreNICE set to endorse talazoparib for adults with BRCA 1 or 2 mutated HER2-negative locally advanced o...
Read moreTibsovo (ivosidenib) has been granted a major additional benefit rating for its use as a first-line ...
Read moreThe Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has implemented the Interna...
Read moreThe statutory scheme has been updated with new percentages for 2024-2026, and has received backlash ...
Read moreGermany’s Health minister has announced that publicly listed AMNOG rebates could be replaced by co...
Read moreAIFA reform is a landmark change which propels Italy towards expedited drug approvals and improved a...
Read more